"This breakthrough is a big step forward in developing new malaria treatments," Yu said. "By focusing on PfNCR1, scientists could develop drugs that the parasite finds difficult to develop resistance ...
Treating the disease is difficult because Plasmodium falciparum, the deadliest malaria parasite, is resistant to nearly all malaria medications. But in a study published today in Science Advances, ...
Researchers at Johns Hopkins are in need of healthy adult male volunteers with type O+ blood to study malaria parasites and sustain mosquito colonies used in crucial malaria research ...